Life sciences, health and social care are vitally important in the development of modern society, with a diverse range of stakeholders, from the general public and clinical practitioners to regulators, insurers and governments. We understand the unique challenges of the industry and deliver results-focused advice for a diverse range of clients, from drug developers to healthcare providers and the entities that finance and support them.
Biotech and pharmaceuticals
In life sciences, we have a strong track record in domestic and cross-border mergers and acquisitions, helping our clients to monetise their assets through creative partnering with early-stage entrepreneurial and established companies, and by providing IP and tax advice.
Our specialist healthcare technology practice advises the companies and investors that are transforming the way therapies and patient services are delivered.
In health and social care, we advise on everything from the building and operating of hospitals and care homes to the provision of new methods of diagnosis and treatment.
Comunicato AIFA sull'applicazione delle norme introdotte dalla Legge Bilancio 2025 in relazione alla maggiorazione della quota di spettanza a favore...